Search results
Found 20324 matches for
In the next few months, the first Phase 3 COVID-19 vaccine trials – the majority of them in upper-middle or high-income countries and in specific target populations like young adults – will report their results. How relevant will their study results be for low-resource settings?
Peter Horby
MSc IHTM Lecturers Principal Investigators Research Scientists
FMedSci Peter Horby - Moh Family Foundation Professor of Emerging Infections and Global Health
Chris Paton
Principal Investigators Research Scientists
Chris Paton - Head of the Global Health Informatics Group
Susanna Dunachie
Principal Investigators Research Scientists
Susanna Dunachie - Professor of Infectious Diseases
François Nosten
Principal Investigators Research Scientists
François Nosten - Professor in Tropical Medicine
Anthony Scott
Principal Investigators Research Scientists
Anthony Scott - Visiting Professor of Vaccinology
Frank Smithuis
Principal Investigators Research Scientists
Frank Smithuis - Professor of Tropical Medicine
James Berkley
MSc IHTM Lecturers Principal Investigators Research Scientists
MBBS MTropMed MRCP MD FRCPCH FMedSci James Berkley - Professor of Paediatric Infectious Diseases
Stuart Blacksell
Principal Investigators Research Scientists
Stuart Blacksell - Professor of Tropical Microbiology
Arjen Dondorp
Principal Investigators Research Scientists
Arjen Dondorp - Professor of Tropical Medicine
Kevin Marsh
MSc IHTM Lecturers MSc IHTM steering committee Principal Investigators Research Scientists
Kevin Marsh - Professor of Tropical Medicine
Trudie Lang
Principal Investigators Research Scientists
Trudie Lang - Professor of Global Health Research
Nicholas Day
MSc IHTM steering committee Principal Investigators Research Scientists
MA BM BCh DM FRCP FMedSci Nicholas Day - Professor of Tropical Medicine